Back to Results
First PageMeta Content
Hepatitis C / AIDS / Microbiology / HIV / Hepacivac / Hepatitis C and HIV co-infection / HIV/AIDS / Health / Medicine


HCV TREATMENT & CARE IN VULNERABLE POPULATIONS: CHALLENGES, OPPORTUNITIES & FUTURE DIRECTIONS NOVEMBER 7TH - 8TH 2013 ROOM: O’CONNOR SALON VICTORIA PARK SUITES (377 O’CONNOR STREET). OTTAWA, CANADA FINAL AGENDA
Add to Reading List

Document Date: 2013-11-15 12:38:46

Open Document

File Size: 513,18 KB

Share Result on Facebook

City

OTTAWA / /

Company

Clinical Management / Janssen Inc. / Treatment Research/Clinical Trials Group / New Frontier Group / Group Exercise Group / /

Country

United States / Canada / China / /

Facility

Capacity Building / University of Alberta / The Ottawa Hospital / Hospital Funding / /

IndustryTerm

Hepatitis C Prevention / Treatment of HCV / HCV Care / HCV TREATMENT / hepatitis treatment / /

MedicalCondition

TB / HIV / chronic HCV / HCV / HIV/AIDS / Viral Hepatitis / hepatitis / undiagnosed infections / /

Organization

Ottawa Hospital / World Health Organization / Sandy Hill Community Health Centre / Public Health Agency of Canada / Canadian Public Health Association / University of Alberta / Canadian Treatment Action Council / Canadian Society for International Health / BC Centre for Excellence / Centers for Disease Control and Prevention / /

Person

Curtis Cooper / CONNOR SALON / VICTORIA PARK / Tom Wong / Julie Bruneau / Fuqiang Cui / Sunil Varghese / Mark Hull / Allan Miranda / Stefan Wiktor / Junior Researcher / Judith Bossé / Kiren Mitruka / Bob Walsh / Colleen Price / Ian Culbert / Paul Sutton / Don Sutherland / Ping Yan / Janet Hatcher Roberts / /

Position

Advocate / Assistant Deputy Minister / Consultant / /

ProvinceOrState

Alberta / /

SocialTag